CINXE.COM

‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood Cancer - MedCity News

<!DOCTYPE html> <html lang="en-US" class="no-js"> <head> <meta charset="UTF-8" /> <meta name="viewport" content="width=device-width, initial-scale=1" /> <link rel="preconnect" href="https://fonts.googleapis.com"> <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin> <link rel="icon" type="image/x-icon" href="https://medcitynews.com/wp-content/themes/medcitynews/dist/images/favicon.ico"> <!-- Author Meta Tags by Molongui Authorship, visit: https://wordpress.org/plugins/molongui-authorship/ --> <meta name="author" content="Frank Vinluan"> <meta property="article:author" content="https://www.facebook.com/" /> <!-- /Molongui Authorship --> <script>(function(html){html.className = html.className.replace(/\bno-js\b/,'js')})(document.documentElement);</script> <meta name='robots' content='index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1' /> <style>img:is([sizes="auto" i], [sizes^="auto," i]) { contain-intrinsic-size: 3000px 1500px }</style> <!-- This site is optimized with the Yoast SEO plugin v23.5 - https://yoast.com/wordpress/plugins/seo/ --> <title>‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood Cancer - MedCity News</title> <link rel="canonical" href="https://medcitynews.com/2024/11/autolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia/" /> <meta property="og:locale" content="en_US" /> <meta property="og:type" content="article" /> <meta property="og:title" content="‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood Cancer - MedCity News" /> <meta property="og:description" content="Autolus Therapeutics’ Aucatzyl is now FDA approved for treating advanced cases of B-cell precursor acute lymphoblastic leukemia. While it goes after the same target as Gilead Sciences’ Tecartus, Autolus engineered its CAR T-therapy with properties that could improve safety, efficacy, and durability." /> <meta property="og:url" content="https://medcitynews.com/2024/11/autolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia/" /> <meta property="og:site_name" content="MedCity News" /> <meta property="article:published_time" content="2024-11-10T17:32:00+00:00" /> <meta property="article:modified_time" content="2024-11-13T19:40:49+00:00" /> <meta property="og:image" content="https://medcitynews.com/wp-content/uploads/sites/7/2024/02/GettyImages-1637352864.jpg" /> <meta property="og:image:width" content="727" /> <meta property="og:image:height" content="480" /> <meta property="og:image:type" content="image/jpeg" /> <meta name="author" content="Frank Vinluan" /> <meta name="twitter:card" content="summary_large_image" /> <meta name="twitter:creator" content="@frankvinluan" /> <meta name="twitter:label1" content="Written by" /> <meta name="twitter:data1" content="Frank Vinluan" /> <meta name="twitter:label2" content="Est. reading time" /> <meta name="twitter:data2" content="1 minute" /> <script type="application/ld+json" class="yoast-schema-graph">{"@context":"https://schema.org","@graph":[{"@type":"WebPage","@id":"https://medcitynews.com/2024/11/autolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia/","url":"https://medcitynews.com/2024/11/autolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia/","name":"‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood Cancer - MedCity News","isPartOf":{"@id":"https://medcitynews.com/#website"},"primaryImageOfPage":{"@id":"https://medcitynews.com/2024/11/autolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia/#primaryimage"},"image":{"@id":"https://medcitynews.com/2024/11/autolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia/#primaryimage"},"thumbnailUrl":"https://medcitynews.com/wp-content/uploads/sites/7/2024/02/GettyImages-1637352864.jpg","datePublished":"2024-11-10T17:32:00+00:00","dateModified":"2024-11-13T19:40:49+00:00","author":{"@id":"https://medcitynews.com/#/schema/person/1cf3c3480579e9fc54a2618be465ccfd"},"breadcrumb":{"@id":"https://medcitynews.com/2024/11/autolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https://medcitynews.com/2024/11/autolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https://medcitynews.com/2024/11/autolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia/#primaryimage","url":"https://medcitynews.com/wp-content/uploads/sites/7/2024/02/GettyImages-1637352864.jpg","contentUrl":"https://medcitynews.com/wp-content/uploads/sites/7/2024/02/GettyImages-1637352864.jpg","width":727,"height":480},{"@type":"BreadcrumbList","@id":"https://medcitynews.com/2024/11/autolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://medcitynews.com/"},{"@type":"ListItem","position":2,"name":"‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood Cancer"}]},{"@type":"WebSite","@id":"https://medcitynews.com/#website","url":"https://medcitynews.com/","name":"MedCity News","description":"Healthcare technology news, life science current events","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://medcitynews.com/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https://medcitynews.com/#/schema/person/1cf3c3480579e9fc54a2618be465ccfd","name":"Frank Vinluan","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https://medcitynews.com/#/schema/person/image/","url":"https://medcitynews.com/wp-content/uploads/sites/7/2023/05/cropped-FrankVinluan_headshot-96x96.jpg","contentUrl":"https://medcitynews.com/wp-content/uploads/sites/7/2023/05/cropped-FrankVinluan_headshot-96x96.jpg","caption":"Frank Vinluan"},"description":"Frank Vinluan is senior biopharma reporter for MedCity News. He previously held business reporting positions at Xconomy, The Seattle Times, The Des Moines Register, and the Triangle Business Journal. LinkedIn: https://www.linkedin.com/in/frankvinluan/ Twitter: @frankvinluan","sameAs":["https://www.linkedin.com/in/frankvinluan/","https://x.com/frankvinluan"],"url":"https://medcitynews.com/author/fvinluan/"}]}</script> <!-- / Yoast SEO plugin. --> <link rel='dns-prefetch' href='//securepubads.g.doubleclick.net' /> <link rel='dns-prefetch' href='//a.omappapi.com' /> <link rel='dns-prefetch' href='//use.typekit.net' /> <link rel="alternate" type="application/rss+xml" title="MedCity News &raquo; Feed" href="https://medcitynews.com/feed/" /> <link rel="alternate" type="application/rss+xml" title="MedCity News &raquo; Comments Feed" href="https://medcitynews.com/comments/feed/" /> <link rel="alternate" type="application/rss+xml" title="MedCity News &raquo; ‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood Cancer Comments Feed" href="https://medcitynews.com/2024/11/autolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia/feed/" /> <link rel='stylesheet' id='wp-block-library-css' href='https://medcitynews.com/wp-includes/css/dist/block-library/style.min.css?ver=6.7.1' type='text/css' media='all' /> <link rel='stylesheet' id='mediaelement-css' href='https://medcitynews.com/wp-includes/js/mediaelement/mediaelementplayer-legacy.min.css?ver=4.2.17' type='text/css' media='all' /> <link rel='stylesheet' id='wp-mediaelement-css' href='https://medcitynews.com/wp-includes/js/mediaelement/wp-mediaelement.min.css?ver=6.7.1' type='text/css' media='all' /> <style id='jetpack-sharing-buttons-style-inline-css' type='text/css'> .jetpack-sharing-buttons__services-list{display:flex;flex-direction:row;flex-wrap:wrap;gap:0;list-style-type:none;margin:5px;padding:0}.jetpack-sharing-buttons__services-list.has-small-icon-size{font-size:12px}.jetpack-sharing-buttons__services-list.has-normal-icon-size{font-size:16px}.jetpack-sharing-buttons__services-list.has-large-icon-size{font-size:24px}.jetpack-sharing-buttons__services-list.has-huge-icon-size{font-size:36px}@media print{.jetpack-sharing-buttons__services-list{display:none!important}}.editor-styles-wrapper .wp-block-jetpack-sharing-buttons{gap:0;padding-inline-start:0}ul.jetpack-sharing-buttons__services-list.has-background{padding:1.25em 2.375em} </style> <style id='global-styles-inline-css' type='text/css'> :root{--wp--preset--aspect-ratio--square: 1;--wp--preset--aspect-ratio--4-3: 4/3;--wp--preset--aspect-ratio--3-4: 3/4;--wp--preset--aspect-ratio--3-2: 3/2;--wp--preset--aspect-ratio--2-3: 2/3;--wp--preset--aspect-ratio--16-9: 16/9;--wp--preset--aspect-ratio--9-16: 9/16;--wp--preset--color--black: #000;--wp--preset--color--cyan-bluish-gray: #abb8c3;--wp--preset--color--white: #fff;--wp--preset--color--pale-pink: #f78da7;--wp--preset--color--vivid-red: #cf2e2e;--wp--preset--color--luminous-vivid-orange: #ff6900;--wp--preset--color--luminous-vivid-amber: #fcb900;--wp--preset--color--light-green-cyan: #7bdcb5;--wp--preset--color--vivid-green-cyan: #00d084;--wp--preset--color--pale-cyan-blue: #8ed1fc;--wp--preset--color--vivid-cyan-blue: #0693e3;--wp--preset--color--vivid-purple: #9b51e0;--wp--preset--color--yellow: #ffcd00;--wp--preset--color--green: #009c3b;--wp--preset--color--red: #e10600;--wp--preset--color--orange: #f5a01a;--wp--preset--color--blue: #007dbc;--wp--preset--color--purple: #6a1b9a;--wp--preset--color--darker-gray: #444;--wp--preset--color--dark-gray: #767676;--wp--preset--color--gray-medium: #C8C8C8;--wp--preset--color--gray: #f9f9f9;--wp--preset--color--light-gray: #f3f3f3;--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple: linear-gradient(135deg,rgba(6,147,227,1) 0%,rgb(155,81,224) 100%);--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan: linear-gradient(135deg,rgb(122,220,180) 0%,rgb(0,208,130) 100%);--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange: linear-gradient(135deg,rgba(252,185,0,1) 0%,rgba(255,105,0,1) 100%);--wp--preset--gradient--luminous-vivid-orange-to-vivid-red: linear-gradient(135deg,rgba(255,105,0,1) 0%,rgb(207,46,46) 100%);--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray: linear-gradient(135deg,rgb(238,238,238) 0%,rgb(169,184,195) 100%);--wp--preset--gradient--cool-to-warm-spectrum: linear-gradient(135deg,rgb(74,234,220) 0%,rgb(151,120,209) 20%,rgb(207,42,186) 40%,rgb(238,44,130) 60%,rgb(251,105,98) 80%,rgb(254,248,76) 100%);--wp--preset--gradient--blush-light-purple: linear-gradient(135deg,rgb(255,206,236) 0%,rgb(152,150,240) 100%);--wp--preset--gradient--blush-bordeaux: linear-gradient(135deg,rgb(254,205,165) 0%,rgb(254,45,45) 50%,rgb(107,0,62) 100%);--wp--preset--gradient--luminous-dusk: linear-gradient(135deg,rgb(255,203,112) 0%,rgb(199,81,192) 50%,rgb(65,88,208) 100%);--wp--preset--gradient--pale-ocean: linear-gradient(135deg,rgb(255,245,203) 0%,rgb(182,227,212) 50%,rgb(51,167,181) 100%);--wp--preset--gradient--electric-grass: linear-gradient(135deg,rgb(202,248,128) 0%,rgb(113,206,126) 100%);--wp--preset--gradient--midnight: linear-gradient(135deg,rgb(2,3,129) 0%,rgb(40,116,252) 100%);--wp--preset--font-size--small: var(--wp--custom--typography--font--size--14);--wp--preset--font-size--medium: var(--wp--custom--typography--font--size--18);--wp--preset--font-size--large: var(--wp--custom--typography--font--size--20);--wp--preset--font-size--x-large: var(--wp--custom--typography--font--size--40);--wp--preset--font-family--sans-serif: "proxima-nova", Helvetica, Arial, sans-serif;--wp--preset--font-family--serif: "georgiapro", sans-serif;--wp--preset--font-family--heading: "proxima-nova", Helvetica, Arial, sans-serif;--wp--preset--font-family--body: var(--wp--preset--font-family--sans-serif);--wp--preset--spacing--20: 0.44rem;--wp--preset--spacing--30: 0.67rem;--wp--preset--spacing--40: 1rem;--wp--preset--spacing--50: 1.5rem;--wp--preset--spacing--60: 2.25rem;--wp--preset--spacing--70: 3.38rem;--wp--preset--spacing--80: 5.06rem;--wp--preset--shadow--natural: 6px 6px 9px rgba(0, 0, 0, 0.2);--wp--preset--shadow--deep: 12px 12px 50px rgba(0, 0, 0, 0.4);--wp--preset--shadow--sharp: 6px 6px 0px rgba(0, 0, 0, 0.2);--wp--preset--shadow--outlined: 6px 6px 0px -3px rgba(255, 255, 255, 1), 6px 6px rgba(0, 0, 0, 1);--wp--preset--shadow--crisp: 6px 6px 0px rgba(0, 0, 0, 1);--wp--custom--color--primary: var(--wp--preset--color--blue);--wp--custom--color--highlight: var(--wp--preset--color--orange);--wp--custom--color--secondary: var(--wp--preset--color--orange);--wp--custom--color--accent: var(--wp--preset--color--orange);--wp--custom--color--link: var(--wp--preset--color--blue);--wp--custom--color--link-hover: var(--wp--preset--color-orange);--wp--custom--width--default: 56rem;--wp--custom--width--wide: 90rem;--wp--custom--width--full: var(--full-width);--wp--custom--spacing--1: 1px;--wp--custom--spacing--2: 2px;--wp--custom--spacing--4: 4px;--wp--custom--spacing--6: 6px;--wp--custom--spacing--8: 8px;--wp--custom--spacing--10: 10px;--wp--custom--spacing--12: 12px;--wp--custom--spacing--16: 16px;--wp--custom--spacing--18: 18px;--wp--custom--spacing--20: 20px;--wp--custom--spacing--22: 22px;--wp--custom--spacing--24: 24px;--wp--custom--spacing--28: 28px;--wp--custom--spacing--30: 30px;--wp--custom--spacing--32: 32px;--wp--custom--spacing--40: 40px;--wp--custom--spacing--48: 48px;--wp--custom--spacing--54: 54px;--wp--custom--spacing--56: 56px;--wp--custom--spacing--60: 60px;--wp--custom--spacing--64: 64px;--wp--custom--spacing--68: 68px;--wp--custom--spacing--72: 72px;--wp--custom--spacing--80: 80px;--wp--custom--spacing--88: 88px;--wp--custom--spacing--96: 96px;--wp--custom--spacing--104: 104px;--wp--custom--spacing--112: 112px;--wp--custom--spacing--120: 120px;--wp--custom--spacing--156: 156px;--wp--custom--spacing--vertical-flow: 40px;--wp--custom--typography--font--size--12: 0.75rem;--wp--custom--typography--font--size--13: 0.8125rem;--wp--custom--typography--font--size--14: 0.875rem;--wp--custom--typography--font--size--15: 0.938rem;--wp--custom--typography--font--size--16: 1rem;--wp--custom--typography--font--size--18: 1.125rem;--wp--custom--typography--font--size--20: 1.25rem;--wp--custom--typography--font--size--22: 1.375rem;--wp--custom--typography--font--size--24: 1.5rem;--wp--custom--typography--font--size--25: 1.5625rem;--wp--custom--typography--font--size--28: 1.75rem;--wp--custom--typography--font--size--30: 1.875rem;--wp--custom--typography--font--size--31: 1.9375rem;--wp--custom--typography--font--size--32: 2rem;--wp--custom--typography--font--size--36: 2.25rem;--wp--custom--typography--font--size--39: 2.4375rem;--wp--custom--typography--font--size--40: 2.5rem;--wp--custom--typography--font--size--49: 3.0625rem;--wp--custom--typography--font--size--57: 3.5625rem;--wp--custom--typography--font--size--61: 3.8125rem;--wp--custom--typography--font--weight--thin: 100;--wp--custom--typography--font--weight--light: 300;--wp--custom--typography--font--weight--normal: 400;--wp--custom--typography--font--weight--medium: 500;--wp--custom--typography--font--weight--semi-bold: 600;--wp--custom--typography--font--weight--bold: 700;}:root { --wp--style--global--content-size: 896px;--wp--style--global--wide-size: 1304px; }:where(body) { margin: 0; }.wp-site-blocks > .alignleft { float: left; margin-right: 2em; }.wp-site-blocks > .alignright { float: right; margin-left: 2em; }.wp-site-blocks > .aligncenter { justify-content: center; margin-left: auto; margin-right: auto; }:where(.is-layout-flex){gap: 0.5em;}:where(.is-layout-grid){gap: 0.5em;}.is-layout-flow > .alignleft{float: left;margin-inline-start: 0;margin-inline-end: 2em;}.is-layout-flow > .alignright{float: right;margin-inline-start: 2em;margin-inline-end: 0;}.is-layout-flow > .aligncenter{margin-left: auto !important;margin-right: auto !important;}.is-layout-constrained > .alignleft{float: left;margin-inline-start: 0;margin-inline-end: 2em;}.is-layout-constrained > .alignright{float: right;margin-inline-start: 2em;margin-inline-end: 0;}.is-layout-constrained > .aligncenter{margin-left: auto !important;margin-right: auto !important;}.is-layout-constrained > :where(:not(.alignleft):not(.alignright):not(.alignfull)){max-width: var(--wp--style--global--content-size);margin-left: auto !important;margin-right: auto !important;}.is-layout-constrained > .alignwide{max-width: var(--wp--style--global--wide-size);}body .is-layout-flex{display: flex;}.is-layout-flex{flex-wrap: wrap;align-items: center;}.is-layout-flex > :is(*, div){margin: 0;}body .is-layout-grid{display: grid;}.is-layout-grid > :is(*, div){margin: 0;}body{padding-top: 0px;padding-right: 0px;padding-bottom: 0px;padding-left: 0px;}a:where(:not(.wp-element-button)){text-decoration: underline;}:root :where(.wp-element-button, .wp-block-button__link){background-color: #32373c;border-width: 0;color: #fff;font-family: inherit;font-size: inherit;line-height: inherit;padding: calc(0.667em + 2px) calc(1.333em + 2px);text-decoration: none;}.has-black-color{color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-color{color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-color{color: var(--wp--preset--color--white) !important;}.has-pale-pink-color{color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-color{color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-color{color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-color{color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-color{color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-color{color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-color{color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-color{color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-color{color: var(--wp--preset--color--vivid-purple) !important;}.has-yellow-color{color: var(--wp--preset--color--yellow) !important;}.has-green-color{color: var(--wp--preset--color--green) !important;}.has-red-color{color: var(--wp--preset--color--red) !important;}.has-orange-color{color: var(--wp--preset--color--orange) !important;}.has-blue-color{color: var(--wp--preset--color--blue) !important;}.has-purple-color{color: var(--wp--preset--color--purple) !important;}.has-darker-gray-color{color: var(--wp--preset--color--darker-gray) !important;}.has-dark-gray-color{color: var(--wp--preset--color--dark-gray) !important;}.has-gray-medium-color{color: var(--wp--preset--color--gray-medium) !important;}.has-gray-color{color: var(--wp--preset--color--gray) !important;}.has-light-gray-color{color: var(--wp--preset--color--light-gray) !important;}.has-black-background-color{background-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-background-color{background-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-background-color{background-color: var(--wp--preset--color--white) !important;}.has-pale-pink-background-color{background-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-background-color{background-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-background-color{background-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-background-color{background-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-background-color{background-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-background-color{background-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-background-color{background-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-background-color{background-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-background-color{background-color: var(--wp--preset--color--vivid-purple) !important;}.has-yellow-background-color{background-color: var(--wp--preset--color--yellow) !important;}.has-green-background-color{background-color: var(--wp--preset--color--green) !important;}.has-red-background-color{background-color: var(--wp--preset--color--red) !important;}.has-orange-background-color{background-color: var(--wp--preset--color--orange) !important;}.has-blue-background-color{background-color: var(--wp--preset--color--blue) !important;}.has-purple-background-color{background-color: var(--wp--preset--color--purple) !important;}.has-darker-gray-background-color{background-color: var(--wp--preset--color--darker-gray) !important;}.has-dark-gray-background-color{background-color: var(--wp--preset--color--dark-gray) !important;}.has-gray-medium-background-color{background-color: var(--wp--preset--color--gray-medium) !important;}.has-gray-background-color{background-color: var(--wp--preset--color--gray) !important;}.has-light-gray-background-color{background-color: var(--wp--preset--color--light-gray) !important;}.has-black-border-color{border-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-border-color{border-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-border-color{border-color: var(--wp--preset--color--white) !important;}.has-pale-pink-border-color{border-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-border-color{border-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-border-color{border-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-border-color{border-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-border-color{border-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-border-color{border-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-border-color{border-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-border-color{border-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-border-color{border-color: var(--wp--preset--color--vivid-purple) !important;}.has-yellow-border-color{border-color: var(--wp--preset--color--yellow) !important;}.has-green-border-color{border-color: var(--wp--preset--color--green) !important;}.has-red-border-color{border-color: var(--wp--preset--color--red) !important;}.has-orange-border-color{border-color: var(--wp--preset--color--orange) !important;}.has-blue-border-color{border-color: var(--wp--preset--color--blue) !important;}.has-purple-border-color{border-color: var(--wp--preset--color--purple) !important;}.has-darker-gray-border-color{border-color: var(--wp--preset--color--darker-gray) !important;}.has-dark-gray-border-color{border-color: var(--wp--preset--color--dark-gray) !important;}.has-gray-medium-border-color{border-color: var(--wp--preset--color--gray-medium) !important;}.has-gray-border-color{border-color: var(--wp--preset--color--gray) !important;}.has-light-gray-border-color{border-color: var(--wp--preset--color--light-gray) !important;}.has-vivid-cyan-blue-to-vivid-purple-gradient-background{background: var(--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple) !important;}.has-light-green-cyan-to-vivid-green-cyan-gradient-background{background: var(--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan) !important;}.has-luminous-vivid-amber-to-luminous-vivid-orange-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange) !important;}.has-luminous-vivid-orange-to-vivid-red-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-orange-to-vivid-red) !important;}.has-very-light-gray-to-cyan-bluish-gray-gradient-background{background: var(--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray) !important;}.has-cool-to-warm-spectrum-gradient-background{background: var(--wp--preset--gradient--cool-to-warm-spectrum) !important;}.has-blush-light-purple-gradient-background{background: var(--wp--preset--gradient--blush-light-purple) !important;}.has-blush-bordeaux-gradient-background{background: var(--wp--preset--gradient--blush-bordeaux) !important;}.has-luminous-dusk-gradient-background{background: var(--wp--preset--gradient--luminous-dusk) !important;}.has-pale-ocean-gradient-background{background: var(--wp--preset--gradient--pale-ocean) !important;}.has-electric-grass-gradient-background{background: var(--wp--preset--gradient--electric-grass) !important;}.has-midnight-gradient-background{background: var(--wp--preset--gradient--midnight) !important;}.has-small-font-size{font-size: var(--wp--preset--font-size--small) !important;}.has-medium-font-size{font-size: var(--wp--preset--font-size--medium) !important;}.has-large-font-size{font-size: var(--wp--preset--font-size--large) !important;}.has-x-large-font-size{font-size: var(--wp--preset--font-size--x-large) !important;}.has-sans-serif-font-family{font-family: var(--wp--preset--font-family--sans-serif) !important;}.has-serif-font-family{font-family: var(--wp--preset--font-family--serif) !important;}.has-heading-font-family{font-family: var(--wp--preset--font-family--heading) !important;}.has-body-font-family{font-family: var(--wp--preset--font-family--body) !important;} :where(.wp-block-post-template.is-layout-flex){gap: 1.25em;}:where(.wp-block-post-template.is-layout-grid){gap: 1.25em;} :where(.wp-block-columns.is-layout-flex){gap: 2em;}:where(.wp-block-columns.is-layout-grid){gap: 2em;} :root :where(.wp-block-pullquote){font-size: 1.5em;line-height: 1.6;} </style> <link rel='stylesheet' id='mcn-fonts-css' href='https://use.typekit.net/esz7ofc.css' type='text/css' media='all' /> <link rel='stylesheet' id='shared-styles-css' href='https://medcitynews.com/wp-content/themes/breakingmedia/dist/css/shared.css?ver=ea575ec024756abfccb7' type='text/css' media='all' /> <link rel='stylesheet' id='mcn-shared-styles-css' href='https://medcitynews.com/wp-content/themes/medcitynews/dist/css/shared.css?ver=8c5b220bf6f482881a90' type='text/css' media='all' /> <link rel='stylesheet' id='frontend-styles-css' href='https://medcitynews.com/wp-content/themes/breakingmedia/dist/css/frontend.css?ver=fe6247813520f8fa9994' type='text/css' media='all' /> <link rel='stylesheet' id='mcn-frontend-styles-css' href='https://medcitynews.com/wp-content/themes/medcitynews/dist/css/frontend.css?ver=8cc541636417109a581d' type='text/css' media='all' /> <script type="text/javascript" src="https://medcitynews.com/wp-includes/js/jquery/jquery.min.js?ver=3.7.1" id="jquery-core-js"></script> <script type="text/javascript" src="https://medcitynews.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=3.4.1" id="jquery-migrate-js"></script> <script type="text/javascript" src="https://securepubads.g.doubleclick.net/tag/js/gpt.js" id="gpt-js" async="async" data-wp-strategy="async"></script> <script type="text/javascript" id="ad-manager-js-extra"> /* <![CDATA[ */ var BMAdData = {"adConfigURL":"https:\/\/medcitynews.com\/wp-content\/themes\/breakingmedia\/assets\/json\/ads-medcitynews.json?ver=20240204a","adTemplate":"post","keyValues":{"channel":["biopharma","daily","legal","pharma-channel"],"pagetype":"post","site":"medcitynews","slug":"%e2%80%98serial-killing%e2%80%99-cell-therapy-from-autolus-lands-fda-approval-in-blood-cancer","tag":["acute-lymphoblastic-leukemia","aucatzyl","autolus-therapeutics","blood-cancer","cancer","car-t","cell-therapy","fda"],"environment":"production","test":"off","author":"frank-vinluan","post_id":131438},"disabledSlots":[],"hasStickyAds":"1","isSponsored":"0","hasInlineLawModule":"0"}; /* ]]> */ </script> <script type="text/javascript" src="https://medcitynews.com/wp-content/themes/breakingmedia/dist/js/ads.js?ver=ea575ec024756abfccb7" id="ad-manager-js" async="async" data-wp-strategy="async"></script> <link rel="https://api.w.org/" href="https://medcitynews.com/wp-json/" /><link rel="alternate" title="JSON" type="application/json" href="https://medcitynews.com/wp-json/wp/v2/posts/131438" /><link rel='shortlink' href='https://medcitynews.com/?p=131438' /> <link rel="alternate" title="oEmbed (JSON)" type="application/json+oembed" href="https://medcitynews.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fmedcitynews.com%2F2024%2F11%2Fautolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia%2F" /> <link rel="alternate" title="oEmbed (XML)" type="text/xml+oembed" href="https://medcitynews.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fmedcitynews.com%2F2024%2F11%2Fautolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia%2F&#038;format=xml" /> <style> .molongui-disabled-link { border-bottom: none !important; text-decoration: none !important; color: inherit !important; cursor: inherit !important; } .molongui-disabled-link:hover, .molongui-disabled-link:hover span { border-bottom: none !important; text-decoration: none !important; color: inherit !important; cursor: inherit !important; } </style> <!-- OneTrust Cookies Consent Notice start --> <script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="b838e07b-6d75-4e19-bd38-14372ef081f5" ></script> <script type="text/javascript"> function OptanonWrapper() { } </script> <!-- OneTrust Cookies Consent Notice end --> <!-- Google Tag Manager --> <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= '//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-WHW9DF');</script> <!-- End Google Tag Manager --> <!--Parse.ly metadata --> <script type="application/ld+json"> { "@context": "https://schema.org", "@type": "NewsArticle", "headline": "‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood Cancer", "url": "https://medcitynews.com/2024/11/autolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia/", "thumbnailUrl": "https://medcitynews.com/wp-content/uploads/sites/7/2024/02/GettyImages-1637352864.jpg" ,"datePublished": "2024-11-10T12:32:00-05:00" ,"articleSection": "BioPharma" ,"creator": ["Frank Vinluan"] ,"keywords": ["BioPharma, Daily, Legal, Pharma"] ,"publisher": { "@type": "Organization", "name": "MedCity News" } } </script> </head> <body class="post-template-default single single-post postid-131438 single-format-standard wp-embed-responsive bm-gutenberg"> <div id="site"> <div class="site-top-bar"> <div class="site-top-bar__inner"> <nav class="nav-social " aria-label="Social Media"> <ul id="nav-social" class="nav-social__items"><li id="menu-item-6249" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-6249"><a href="https://twitter.com/medcitynews">Twitter</a></li> <li id="menu-item-6252" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-6252"><a href="https://facebook.com/medcitynews">Facebook</a></li> <li id="menu-item-124860" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-124860"><a href="https://www.linkedin.com/company/medcity-news/">LinkedIn</a></li> <li id="menu-item-6255" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-6255"><a href="/feed/">RSS</a></li> <li id="menu-item-6258" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-6258"><a href="/subscribe/">Subscribe via email</a></li> </ul></nav> <nav class="nav-secondary " aria-label="Secondary"> <ul id="nav-secondary" class="nav-secondary__items"><li id="menu-item-124858" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-124858"><a href="https://medcitynews.com/subscribe/">Newsletter Signup</a></li> <li id="menu-item-124859" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-124859"><a href="/cdn-cgi/l/email-protection#04706d747744696160676d707d6a6173772a676b69">Send Tips</a></li> </ul></nav> </div> </div> <header id="site-header" class="site-header"> <div class="site-header__top"> <div class="site-header__wrapper"> <button class="site-header__nav-toggle js-nav-toggle" aria-controls="site-header-nav-bar" aria-expanded="false"> <span class="site-header__nav-toggle-icon" aria-hidden="true"> <span></span> <span></span> <span></span> </span> <span class="screen-reader-text">Open navigation</span> </button> <figure class="site-header__title logo-wrapper"> <a id="logo" class="site-header__logo" href="https://medcitynews.com/"> <span class="visually-hidden">MedCity News</span> <svg xmlns="http://www.w3.org/2000/svg" xml:space="preserve" aria-hidden="true" viewBox="0 0 600 83"><switch><g fill="#231F20"><path d="M0 52.9h8.1V11.6H0V1h31.3L45 37.6 59.2 1h31.6v10.6h-8.1v41.3H91v10.6H58.8V52.9H67V11.6h-1.5L46 63.5h-6.8L19.7 11.6h-1.5v41.3h8.2v10.6H0V52.9zm139 .9c-4.5 7-11.9 10.7-21.3 10.7-15.1 0-24.6-8.5-24.6-22 0-13.6 9.8-23.5 23.5-23.5 13.1 0 23.5 10 22.4 25.7h-31.8c.1 5 2.8 10.9 10.7 10.9 3.7 0 6.1-1.2 10.1-5.1l11 3.3zm-13.7-16.9c-.7-5.5-4.1-8.8-9.2-8.8s-8.1 2.9-8.9 8.8h18.1zm69.1 26.6h-20.8v-5.2c-4.2 4.1-7.9 5.8-12.6 5.8-10.7 0-18.8-9.7-18.8-22.6 0-12.7 8.2-22.5 18.9-22.5 4.9 0 9.3 2.1 12.5 5.8V11h-6.7V1h20.8v52.4h6.7v10.1zM165 30.4c-5.2 0-8.5 4.3-8.5 11.4 0 7 3.3 11.6 8.6 11.6 4.3 0 8.7-3.4 8.7-11.9 0-6.5-3.3-11.1-8.8-11.1zM258.1 1v22h-10.6c-1.1-2.9-3-6.3-4.8-7.7-4.4-3.4-6.7-4.1-10.8-4.1-11.2 0-18.6 8.5-18.6 21.2 0 12.1 7.2 20.5 17.6 20.5 8.6 0 15.1-6 17.4-16.3l12.3 5.9C256 59.3 242 64.3 229.7 64.3c-26.7 0-33.8-18.5-33.8-32.1 0-19 13.3-32.2 32.8-32.2 7.6 0 13.6 1.8 18.8 5.9V1h10.6zm6.6 19h20.4v33.5h6.3v10h-26.8v-10h6.3V30h-6.3V20zm21.2-12.5c0 4.2-3.4 7.6-7.6 7.6s-7.5-3.4-7.5-7.6S274 0 278.2 0s7.7 3.3 7.7 7.5zm5.6 12.5h5.5v-6.8l14.1-9.9V20h7.8v10h-7.8v18.9c0 3.8.6 4.5 3.6 4.5 1.5 0 2.3-.2 4.2-.8V62c-3.5 1.5-7 2.2-10.4 2.2-5.5 0-11.5-2.7-11.5-10.4V30h-5.5V20zm41.2 52.9h8.3l2.9-7.7L328.1 30h-6.3V20H347v10h-4.2l7.3 19.5 7.7-19.5H353V20h22.1v10h-6.3l-20.9 53h-15.2V72.9zm59.2-64.1H383V1h21.3l27 48.6h.2V8.8h-8.7V1h25.7v7.8h-9.2v55.3h-9.8l-29.6-53.3h-.2v44.9h9v7.8H383v-7.8h8.9V8.8zm63.2 35.1c1.3 8.5 6.8 13.3 14.9 13.3 5.6 0 10.9-2.5 14.1-7.1l7.5 3.3c-4.7 7.3-12.5 11.3-21.8 11.3-14.1 0-24.2-9.6-24.2-23 0-14.1 11.5-23 22.8-23 12 0 23.2 9.2 23.2 25.1h-36.5zm27.8-6.3c-1.4-6.9-7.5-12-14.3-12s-12 4.7-13.2 12h27.5zm13.8-10h-5.3v-7.5h18.3v7.5h-5.6l8.2 26.2h.2l8.2-26.2h-4.8v-7.5H537v7.5h-4.7l8.2 26.2h.2l8.3-26.2h-6.1v-7.5h19.6v7.5h-6.2l-11.7 36.6h-8l-9.8-31.5h-.2l-10.1 31.5h-8.1l-11.7-36.6zm67.6 21h7.6V50c.7 4.3 4.7 7 10.4 7 5.4 0 8.9-2.1 8.9-5.4 0-8.1-15.3-2.9-23.5-11.2-2-2-3.4-5.1-3.4-8.3 0-7.5 6.4-12.8 15.3-12.8 4 0 7.7.9 10.6 2.5v-1.7h7.5v14.3h-7.5v-2.7c-2.5-3.7-5.7-5.3-10.1-5.3-4.6 0-7.6 2.1-7.6 5.3 0 7.3 16.7 3 23.9 10.2 2.6 2.6 3.7 6 3.7 9 0 7.9-6.7 13.2-16.6 13.2-4.7 0-8.3-1-11.4-3.1v2.4h-7.6V48.6z"/></g></switch></svg> </a> </figure> <button class="site-header__search-toggle js-nav-toggle" aria-hidden="true" aria-controls="site-header-nav-bar" aria-expanded="false"> <svg class="icon icon--search" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" width="24" height="25" fill="none"><path fill="currentColor" d="M10.08 2.3a8.154 8.154 0 0 0-8.16 8.16 8.154 8.154 0 0 0 8.16 8.16c1.61 0 3.101-.472 4.365-1.275l5.895 5.895 2.04-2.04-5.82-5.805a8.102 8.102 0 0 0 1.68-4.935 8.154 8.154 0 0 0-8.16-8.16Zm0 1.92a6.228 6.228 0 0 1 6.24 6.24 6.228 6.228 0 0 1-6.24 6.24 6.228 6.228 0 0 1-6.24-6.24 6.228 6.228 0 0 1 6.24-6.24Z"/></svg> <span class="visually-hidden">Toggle Search</span> </button> </div> </div> <div id="site-header-nav-bar" class="site-header__nav-bar" aria-hidden="true"> <nav class="nav-primary " aria-label="Primary"> <ul id="site-header-primary" class="nav-primary__items"><li id="menu-item-6204" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-has-children menu-item-6204"><a href="https://medcitynews.com/category/news/?utm_source=mn-1">News</a> <ul class="sub-menu"> <li id="menu-item-6207" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-6207"><a href="https://medcitynews.com/category/channel/health-tech/?utm_source=mn-1">Health Tech</a></li> <li id="menu-item-6210" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-6210"><a href="https://medcitynews.com/category/channel/biopharma/?utm_source=mn-1">BioPharma</a></li> <li id="menu-item-6213" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-6213"><a href="https://medcitynews.com/category/channel/medical-devices-and-diagnostics/?utm_source=mn-1">Devices &#038; Diagnostics</a></li> <li id="menu-item-6216" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-6216"><a href="https://medcitynews.com/category/channel/consumer-employer/?utm_source=mn-1">Consumer / Employer</a></li> </ul> </li> <li id="menu-item-6219" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-has-children menu-item-6219"><a href="https://medcitynews.com/category/medcity-influencers/?utm_source=mn-1">Contributors</a> <ul class="sub-menu"> <li id="menu-item-6222" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-6222"><a href="https://medcitynews.com/category/medcity-influencers/?utm_source=mn-1">MedCity Influencers</a></li> </ul> </li> <li id="menu-item-6228" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-has-children menu-item-6228"><a>Events</a> <ul class="sub-menu"> <li id="menu-item-6231" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-6231"><a href="https://medcityinvestconference.com/">INVEST</a></li> <li id="menu-item-133223" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-133223"><a href="https://medcityinvestconference.com/digitalhealth">INVEST Digital Health</a></li> </ul> </li> <li id="menu-item-6240" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-6240"><a href="https://medcitynews.com/medcity-podcasts/">Podcasts</a></li> <li id="menu-item-6243" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-6243"><a href="https://hub.medcitynews.com/">Research</a></li> <li id="menu-item-6246" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-6246"><a href="https://medcitynews.com/subscribe/">Newsletters</a></li> </ul></nav> <nav class="nav-secondary nav-secondary--mobile" aria-label="Secondary"> <ul id="nav-secondary" class="nav-secondary__items"><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-124858"><a href="https://medcitynews.com/subscribe/">Newsletter Signup</a></li> <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-124859"><a href="/cdn-cgi/l/email-protection#d1a5b8a1a291bcb4b5b2b8a5a8bfb4a6a2ffb2bebc">Send Tips</a></li> </ul></nav> <nav class="nav-social nav-social--mobile" aria-label="Social Media"> <ul id="nav-social" class="nav-social__items"><li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-6249"><a href="https://twitter.com/medcitynews">Twitter</a></li> <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-6252"><a href="https://facebook.com/medcitynews">Facebook</a></li> <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-124860"><a href="https://www.linkedin.com/company/medcity-news/">LinkedIn</a></li> <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-6255"><a href="/feed/">RSS</a></li> <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-6258"><a href="/subscribe/">Subscribe via email</a></li> </ul></nav> <div id="site-search-67b8b9b6cf0f2" class="site-search" itemscope itemtype="http://schema.org/WebSite"> <form role="search" id="searchform" class="site-search__form" method="get" action="https://medcitynews.com/"> <meta itemprop="target" content="https://medcitynews.com/?s={s}" /> <label for="site-search-67b8b9b6cf0f2-search-field" class="site-search__label visually-hidden"> Search for: </label> <input class="site-search__term" itemprop="query-input" type="search" id="site-search-67b8b9b6cf0f2-search-field" placeholder="Search..." name="s" /> <button class="site-search__button"> <svg class="icon icon--search" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" width="24" height="25" fill="none"><path fill="currentColor" d="M10.08 2.3a8.154 8.154 0 0 0-8.16 8.16 8.154 8.154 0 0 0 8.16 8.16c1.61 0 3.101-.472 4.365-1.275l5.895 5.895 2.04-2.04-5.82-5.805a8.102 8.102 0 0 0 1.68-4.935 8.154 8.154 0 0 0-8.16-8.16Zm0 1.92a6.228 6.228 0 0 1 6.24 6.24 6.228 6.228 0 0 1-6.24 6.24 6.228 6.228 0 0 1-6.24-6.24 6.228 6.228 0 0 1 6.24-6.24Z"/></svg> <span class="visually-hidden">Search</span> </button> </form> </div> </div> <div class="ad ad--top_leaderboard--desktop ad--format-leaderboard ad--desktop-only" id="ad--top_leaderboard--desktop top_leaderboard--desktop"> <div class="ad__wrapper"> <div id="ad-top_leaderboard--desktop"></div> </div> </div> <div class="ad ad--interstitial ad--format-oop" id="ad--interstitial interstitial"> <div class="ad__wrapper"> <div id="ad-interstitial"></div> </div> </div> <div class="ad ad--skin ad--format-1x1 ad--desktop-only" id="ad--skin skin"> <div class="ad__wrapper"> <div id="ad-skin"></div> </div> </div> </header> <div id="site-main" class="site-main"> <main id="single-article" class="single-article post-single" role="main" tabindex="-1"> <header class="post-single__header"> <div class="post-single__categories"> <span class="post-single__category post-single__category--text"> <a href="https://medcitynews.com/category/channel/biopharma/" rel="category tag"> BioPharma, </a> </span> <span class="post-single__category post-single__category--text"> <a href="https://medcitynews.com/category/channel/pharma-channel/" rel="category tag"> Pharma </a> </span> </div> <h1 class="post-single__title"> ‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood Cancer </h1> <div class="post-single__excerpt"> <p>Autolus Therapeutics’ Aucatzyl is now FDA approved for treating advanced cases of B-cell precursor acute lymphoblastic leukemia. While it goes after the same target as Gilead Sciences’ Tecartus, Autolus engineered its CAR T-therapy with properties that could improve safety, efficacy, and durability. </p> </div> <div class="post-single__meta"> <div class="post-single__byline"> <span class="post-single__byline-author">By <a href="https://medcitynews.com/author/fvinluan/">Frank Vinluan</a> <span> on November 10, 2024</span> </span> </div> <div class="post-social-share"> <button class="post-social-share__trigger"> <div class="post-social-share__icon"> <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--!Font Awesome Free 6.5.2 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free Copyright 2024 Fonticons, Inc.--><path d="m503.7 189.8-176-151.9C312.3 24.5 288 35.3 288 56v80.1c-160.6 1.8-288 34-288 186.2 0 61.4 39.6 122.3 83.3 154.1 13.7 9.9 33.1-2.5 28.1-18.6-45.3-145 21.5-183.5 176.6-185.7V360c0 20.7 24.3 31.5 39.7 18.2l176-152c11.1-9.6 11.1-26.8 0-36.3z"/></svg> </div> <span class="post-social-share__label"><strong>Share</strong></span> </button> <div class="post-social-share__container"> <p class="post-social-share__container__heading"><strong>Share Options</strong></p> <p class="post-social-share__container__description">Share a link too this article</p> <ul class="post-social-share__items"> <li class="post-social-share__item"> <button class="post-social-share__link js-social-share-copy js-copy-to-clipboard" data-link="https://medcitynews.com/2024/11/autolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia/"> <span class="post-social-share__icon"> <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 640 512"><!--!Font Awesome Free 6.5.2 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free Copyright 2024 Fonticons, Inc.--><path d="M579.8 267.7c56.5-56.5 56.5-148 0-204.5-50-50-128.8-56.5-186.3-15.4l-1.6 1.1c-14.4 10.3-17.7 30.3-7.4 44.6s30.3 17.7 44.6 7.4l1.6-1.1c32.1-22.9 76-19.3 103.8 8.6 31.5 31.5 31.5 82.5 0 114L422.3 334.8c-31.5 31.5-82.5 31.5-114 0-27.9-27.9-31.5-71.8-8.6-103.8l1.1-1.6c10.3-14.4 6.9-34.4-7.4-44.6s-34.4-6.9-44.6 7.4l-1.1 1.6C206.5 251.2 213 330 263 380c56.5 56.5 148 56.5 204.5 0l112.3-112.3zM60.2 244.3c-56.5 56.5-56.5 148 0 204.5 50 50 128.8 56.5 186.3 15.4l1.6-1.1c14.4-10.3 17.7-30.3 7.4-44.6s-30.3-17.7-44.6-7.4l-1.6 1.1c-32.1 22.9-76 19.3-103.8-8.6C74 372 74 321 105.5 289.5l112.2-112.3c31.5-31.5 82.5-31.5 114 0 27.9 27.9 31.5 71.8 8.6 103.9l-1.1 1.6c-10.3 14.4-6.9 34.4 7.4 44.6s34.4 6.9 44.6-7.4l1.1-1.6C433.5 260.8 427 182 377 132c-56.5-56.5-148-56.5-204.5 0L60.2 244.3z"/></svg> </span> <span class="post-social-share__label">Copy Link</span> <span class="post-social-share__label--fixed js-social-share-label">Copy Link</span> </button> </li> <li class="post-social-share__item"> <a href="/cdn-cgi/l/email-protection#8cb3eee3e8f5b1e4f8f8fcffb6a3a3e1e9e8efe5f8f5e2e9fbffa2efe3e1a3bebcbeb8a3bdbda3edf9f8e3e0f9ffa1efedfea1f8a1efe9e0e0a1f8e4e9feedfcf5a1e3eee9a1efe9e0a1edf9efedf8f6f5e0a1eae8eda1edfcfcfee3faede0a1eea1efe9e0e0a1ede0e0a1eee0e3e3e8a1efede2efe9fea1e0e9f9e7e9e1e5eda3" target="_blank" class="post-social-share__link"> <span class="post-social-share__icon"> <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--!Font Awesome Free 6.5.2 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free Copyright 2024 Fonticons, Inc.--><path d="M502.3 190.8c3.9-3.1 9.7-.2 9.7 4.7V400c0 26.5-21.5 48-48 48H48c-26.5 0-48-21.5-48-48V195.6c0-5 5.7-7.8 9.7-4.7 22.4 17.4 52.1 39.5 154.1 113.6 21.1 15.4 56.7 47.8 92.2 47.6 35.7.3 72-32.8 92.3-47.6 102-74.1 131.6-96.3 154-113.7zM256 320c23.2.4 56.6-29.2 73.4-41.4 132.7-96.3 142.8-104.7 173.4-128.7 5.8-4.5 9.2-11.5 9.2-18.9v-19c0-26.5-21.5-48-48-48H48C21.5 64 0 85.5 0 112v19c0 7.4 3.4 14.3 9.2 18.9 30.6 23.9 40.7 32.4 173.4 128.7 16.8 12.2 50.2 41.8 73.4 41.4z"/></svg> </span> <span class="post-social-share__label">Email</span> </a> </li> <li class="post-social-share__item"> <a href="https://www.facebook.com/sharer/sharer.php?u=https://medcitynews.com/2024/11/autolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia/" target="_blank" class="post-social-share__link"> <span class="post-social-share__icon"> <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512" style="enable-background:new 0 0 448 512" xml:space="preserve"><path class="st0" d="M64 32C28.7 32 0 60.7 0 96v320c0 35.3 28.7 64 64 64h98.2V334.2h-52.8V256h52.8v-33.7c0-87.1 39.4-127.5 125-127.5 16.2 0 44.2 3.2 55.7 6.4V172c-6-.6-16.5-1-29.6-1-42 0-58.2 15.9-58.2 57.2V256h83.6l-14.4 78.2H255V480h129c35.3 0 64-28.7 64-64V96c0-35.3-28.7-64-64-64H64z"/></svg> </span> <span class="post-social-share__label">Facebook</span> </a> </li> <li class="post-social-share__item"> <a href="https://www.linkedin.com/cws/share?url=https://medcitynews.com/2024/11/autolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia/" target="_blank" class="post-social-share__link"> <span class="post-social-share__icon"> <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512"><!--!Font Awesome Free 6.5.2 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free Copyright 2024 Fonticons, Inc.--><path d="M416 32H31.9C14.3 32 0 46.5 0 64.3v383.4C0 465.5 14.3 480 31.9 480H416c17.6 0 32-14.5 32-32.3V64.3c0-17.8-14.4-32.3-32-32.3zM135.4 416H69V202.2h66.5V416zm-33.2-243c-21.3 0-38.5-17.3-38.5-38.5S80.9 96 102.2 96c21.2 0 38.5 17.3 38.5 38.5 0 21.3-17.2 38.5-38.5 38.5zm282.1 243h-66.4V312c0-24.8-.5-56.7-34.5-56.7-34.6 0-39.9 27-39.9 54.9V416h-66.4V202.2h63.7v29.2h.9c8.9-16.8 30.6-34.5 62.9-34.5 67.2 0 79.7 44.3 79.7 101.9V416z"/></svg> </span> <span class="post-social-share__label">LinkedIn</span> </a> </li> <li class="post-social-share__item"> <a href="https://twitter.com/intent/tweet?url=https://medcitynews.com/2024/11/autolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia/" target="_blank" class="post-social-share__link"> <span class="post-social-share__icon"> <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512" style="enable-background:new 0 0 512 512" xml:space="preserve"><path class="st0" d="M389.2 48h70.6L305.6 224.2 487 464H345L233.7 318.6 106.5 464H35.8l164.9-188.5L26.8 48h145.6l100.5 132.9L389.2 48zm-24.8 373.8h39.1L151.1 88h-42l255.3 333.8z"/></svg> </span> <span class="post-social-share__label">X</span> </a> </li> </ul> </div> </div> </div> </header> <article class="post-single__article"> <div class="ad ad--top_leaderboard--mobile ad--format-leaderboard ad--mobile-only" id="ad--top_leaderboard--mobile top_leaderboard--mobile"> <div class="ad__wrapper"> <div id="ad-top_leaderboard--mobile"></div> </div> </div> <div class="content"> <figure class="post-single__featured-image"> <img width="600" height="396" src="https://medcitynews.com/wp-content/uploads/sites/7/2024/02/GettyImages-1637352864-600x396.jpg" class="attachment-large size-large wp-post-image" alt="" decoding="async" fetchpriority="high" srcset="https://medcitynews.com/wp-content/uploads/sites/7/2024/02/GettyImages-1637352864-600x396.jpg 600w, https://medcitynews.com/wp-content/uploads/sites/7/2024/02/GettyImages-1637352864-300x198.jpg 300w, https://medcitynews.com/wp-content/uploads/sites/7/2024/02/GettyImages-1637352864.jpg 727w" sizes="(max-width: 600px) 100vw, 600px" /> </figure> <div class="post-single__content"> <p>An Autolus Therapeutics cell therapy has won <a href="https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-obecabtagene-autoleucel-adults-relapsed-or-refractory-b-cell-precursor-acute" target="_blank" rel="noopener">FDA approval</a> for treating an aggressive blood cancer. It&rsquo;s the biotech&rsquo;s first approved product and just the second CAR T-treatment for adults who have this particular malignancy. But compared to that other cell therapy and other treatments available, Autolus&rsquo;s therapy has features that could set it apart from the field.</p> <p>The Autolus therapy, known in development as obecabtagene autoleucel, or obe-cel, is approved to treat adults with advanced cases of B-cell precursor acute lymphoblastic leukemia (ALL). The Friday approval came ahead of the Nov. 16 target date for an FDA decision. London-based Autolus will market its new therapy under the name Aucatzyl.</p> <p>In B-cell ALL, the bone marrow produces too many abnormal B-lymphocytes, a type of white blood cell. Aucatzyl is a CAR T-cell therapy made by harvesting a patient&rsquo;s T cells and engineering them to go after CD19, a protein abundant on the surfaces of those abnormal cells. It&rsquo;s the same target addressed by Gilead Sciences&rsquo; Tecartus, which received <a href="https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-brexucabtagene-autoleucel-relapsed-or-refractory-b-cell-precursor-acute-lymphoblastic" target="_blank" rel="noopener">FDA approval for ALL in 2021</a>. But Aucatzyl is engineered to offer better safety and efficacy.</p> <div><div class="ad ad--inline_top ad--format-square ad--mobile-only" id="ad--inline_top inline_top"> <div class="ad__wrapper"> <div id="ad-inline_top"></div> </div> </div> <div class="post-card__wrapper has-sponsor-banner post-card--is-sponsored has-gray-background"> <div class="presented-by-sponsor-banner presented-by-parlance" style="border-bottom: 5px solid"> <div class="presented-by-text"> presented by </div> <div class="presented-by-sponsor-logo"> <img src="https://medcitynews.com/wp-content/uploads/sites/7/2024/07/Parlance_Logo-1-1024x300.jpg" style="width: 115px;height: auto" loading="lazy"> </div> </div> <article id="post-133380" class="post-card post-card--has-thumbnail " data-title="What Keeps Healthcare CIOs Up at Night: Balancing Technology Investments with Consumer Expectations&nbsp;" data-url="https://medcitynews.com/2025/01/what-keeps-healthcare-cios-up-at-night-balancing-technology-investments-with-consumer-expectations/"> <div class="post-card__categories"> <span class="post-single__category post-single__category--text"> <a href="https://medcitynews.com/category/channel/artificial-intelligence/" rel="category tag"> Artificial Intelligence </a> </span> </div> <figure class="post-card__thumbnail"> <a href="https://medcitynews.com/2025/01/what-keeps-healthcare-cios-up-at-night-balancing-technology-investments-with-consumer-expectations/" class="post-card__thumbnail-link"> <img width="360" height="200" src="https://medcitynews.com/wp-content/uploads/sites/7/2025/01/GettyImages-153405991-360x200.jpg" class="attachment-post-card-sm size-post-card-sm wp-post-image" alt="" decoding="async" srcset="https://medcitynews.com/wp-content/uploads/sites/7/2025/01/GettyImages-153405991-360x200.jpg 360w, https://medcitynews.com/wp-content/uploads/sites/7/2025/01/GettyImages-153405991-576x320.jpg 576w" sizes="(max-width: 360px) 100vw, 360px"> </a> </figure> <div class="post-card__content"> <h3 class="post-card__title"> <a href="https://medcitynews.com/2025/01/what-keeps-healthcare-cios-up-at-night-balancing-technology-investments-with-consumer-expectations/" class="post-single__title-link"> What Keeps Healthcare CIOs Up at Night: Balancing Technology Investments with Consumer Expectations&nbsp; </a> </h3> <p class="post-card__excerpt content"> When it comes to managing inbound phone calls, underperformance has devastating cost implications. </p> <div class="post-card__byline"> <a href="https://medcitynews.com/2024/11/autolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia/"> By Stephanie Baum </a> </div> </div> </article> </div> <div class="ad ad--youtube1x1 ad--format-1x1" id="ad--youtube1x1 youtube1x1"> <div class="ad__wrapper"> <div id="ad-youtube1x1"></div> </div> </div> </div><p>After recognizing and binding to CD19, Aucatzyl injects its cytotoxic proteins and then disengages from the cancer cell to move on to another cancer cell, a process called &ldquo;serial killing.&rdquo; To be fair, other CAR T-therapies, including Tecartus, offer serial killing capability. But Aucatzyl is designed to disengage from each target cell more rapidly than other cell therapies do. This fast &ldquo;off-rate&rdquo; is intended to minimize excessive activation of T cells, which in turn could reduce adverse effects to patients. This property could also reduce exhaustion of these engineered cells, thereby improving the therapy&rsquo;s durability.</p> <p>The FDA&rsquo;s decision for Aucatzyl is based on the results of an open-label, single-arm trial that enrolled adults with CD19-positive B-cell ALL that had relapsed or had not responded to at least two earlier lines of treatment. The main goal was to measure the rate and duration of complete remission. Of the 65 patients who could be evaluated for efficacy, 27 (42%) achieved complete remission within three months. The median duration of that response was 14.1 months.</p> <p>Aucatzyl&rsquo;s label carries a black box warning for an excessive immune response called cytokine release syndrome. The warning also flags risks of neurotoxicity and T cell malignancies. <a href="https://medcitynews.com/2024/01/fda-calls-for-new-safety-warning-for-the-class-of-car-t-cancer-therapies/" target="_blank" rel="noopener">Those risks are consistent with the class of CAR T-therapies, which also carry black box warnings</a>. But the rates of severe complications for the Autolus therapy were low. While cytokine release syndrome was reported in 75% of patients, this complication was classified at Grade 3 in just 3% of patients and there were no Grade 4 or 5 events. Neurotoxicity was reported in 64% of participants; this complication was Grade 3 or higher in just 12% of cases.</p> <div class="ad ad--inline_middle ad--format-square ad--mobile-only" id="ad--inline_middle inline_middle"> <div class="ad__wrapper"> <div id="ad-inline_middle"></div> </div> </div><p>In a note sent to investors on Friday, William Blair analyst Matt Phipps said the response rates for Aucatzyl are similar to those of Tecartus. Where Autolus&rsquo;s drug differentiates itself is with better safety. Phipps notes that Aucatzyl&rsquo;s rates of complications are lower. He added that unlike other CAR T-therapies, the FDA is not requiring the Autolus product to have a risk evaluation mitigation strategy (REMS), a program that monitors and mitigates the risks of a treatment.</p> <div class="post-card__wrapper post-card--is-sponsored "> <article id="post-133082" class="post-card post-card--has-thumbnail " data-title="Improving the Healthcare Financial Experience to Help Care Flow" data-url="https://medcitynews.com/2025/01/improving-the-healthcare-financial-experience-to-help-care-flow/"> <div class="post-card__categories"> <span class="post-single__category post-single__category--text"> <a href="https://medcitynews.com/category/exclusive/" rel="category tag"> Exclusive </a> </span> </div> <figure class="post-card__thumbnail"> <a href="https://medcitynews.com/2025/01/improving-the-healthcare-financial-experience-to-help-care-flow/" class="post-card__thumbnail-link"> <img width="360" height="200" src="https://medcitynews.com/wp-content/uploads/sites/7/2025/01/Amanda-EiselThumbnail-360x200.jpg" class="attachment-post-card-sm size-post-card-sm wp-post-image" alt="" decoding="async"> </a> </figure> <div class="post-card__content"> <h3 class="post-card__title"> <a href="https://medcitynews.com/2025/01/improving-the-healthcare-financial-experience-to-help-care-flow/" class="post-single__title-link"> Improving the Healthcare Financial Experience to Help Care Flow </a> </h3> <p class="post-card__excerpt content"> Zelis CEO Amanda Eisel shares her perspective on how the company is solving the problems of a fragmented health financial system to benefit all. </p> <div class="post-card__byline"> <a href="https://medcitynews.com/2024/11/autolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia/"> By Stephanie Baum </a> </div> </div> </article> </div><p>&ldquo;We continue to believe the more tolerable safety profile of Aucatzyl will make it the preferred treatment option for patients with adult ALL and support majority market share over time,&rdquo; Phipps said. &ldquo;Interestingly, Aucatzyl is the first CAR T-therapy to be approved without a REMS requirement, which should reduce burden for the treating centers and further support adoption.&rdquo;</p> <p>Aucatzyl&rsquo;s safety edge could also support expanding the product&rsquo;s uses to certain autoimmune disorders driven by excessive B-cell activity. Earlier this year, Autolus began an open-label Phase 1 study evaluating Aucatzyl in systemic lupus erythematosus. Autolus has said that depending on the outcome of this test, it could proceed to further studies in lupus and lupus nephritis among other autoimmune disorders.</p> <div class="ad ad--inline_bottom ad--format-square ad--mobile-only" id="ad--inline_bottom inline_bottom"> <div class="ad__wrapper"> <div id="ad-inline_bottom"></div> </div> </div><p>In the nearer term, Autolus is focusing on commercialization of Aucatzyl in ALL. An Autolus manufacturing facility in Stevenage, United Kingdom, will produce the therapy for global markets. The therapy is still under regulatory review in Europe. Cardinal Health is the distribution partner for the product in the U.S.</p> <p>Aucatzyl enters an ALL market dominated by Amgen&rsquo;s Blincyto, a bispecific antibody designed to target CD19 on B cells and CD3 on T cells. This drug is approved for treating ALL in adults and pediatric patients. Amgen reported <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm" target="_blank" rel="noopener">$861 million in 2023 sales</a> for the product, a 48% year-over-year increase. But this drug&rsquo;s label carries a black box warning for cytokine release syndrome and neurotoxicity. It also offers limited durability. Meanwhile, Tecartus is not a big revenue generator for Gilead, but sales are growing. For 2023, the company <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/882095/000088209524000007/gild-20231231.htm" target="_blank" rel="noopener">reported $370 million</a> in global Tecartus sales, a nearly 23.7% increase compared to the same period in in the prior year. Novartis&rsquo;s CD19-targeting CAR T-therapy, Kymriah, is approved for treating ALL in patients up to age 25.</p> <p>[<em>Paragraph updated with additional analyst commentary.</em>] In a Monday research note, William Blair&rsquo;s Phipps said the lack of a REMS requirement removes administrative and logistical burdens from the sites that administer Aucatzyl as well as training requirements, which could result in a faster ramp-up of the therapy. Aucatzyl carries a $525,000 wholesale price, reflecting the therapy&rsquo;s clinical evidence, differentiated safety, and economic value, Autolus said in an <a href="https://autolus.gcs-web.com/static-files/620409a6-9f81-4834-a9ad-a92c58784ea8" target="_blank" rel="noopener">investor presentation</a>. That price represents a roughly 11% premium to Tecartus&rsquo;s list price in adult ALL. While William Blair initially expected the Autolus drug&rsquo;s price would be in line with the Gilead product, Phipps said Aucatzyl&rsquo;s differentiation on safety and REMS reporting warrants a premium price point. Aucatzyl costs less than the $580,000 price of Novartis&rsquo;s Kymriah. Phipps noted drugs approved for the pediatric setting typically carry higher prices.</p> <p><em>Image: Getty Images</em></p> </div> </div> <footer class="post-single__footer"> <div class="post-single__topics"> <h2 class="post-single__topic-title">Topics</h2> <ul class="post-single__tags list-none"> <li class="post-single__tag-item"> <a class="post-single__tag" href="https://medcitynews.com/tag/acute-lymphoblastic-leukemia/ " rel="tag">acute lymphoblastic leukemia</a> </li> <li class="post-single__tag-item"> <a class="post-single__tag" href="https://medcitynews.com/tag/aucatzyl/ " rel="tag">Aucatzyl</a> </li> <li class="post-single__tag-item"> <a class="post-single__tag" href="https://medcitynews.com/tag/autolus-therapeutics/ " rel="tag">Autolus Therapeutics</a> </li> <li class="post-single__tag-item"> <a class="post-single__tag" href="https://medcitynews.com/tag/blood-cancer/ " rel="tag">blood cancer</a> </li> <li class="post-single__tag-item"> <a class="post-single__tag" href="https://medcitynews.com/tag/cancer/ " rel="tag">cancer</a> </li> <li class="post-single__tag-item"> <a class="post-single__tag" href="https://medcitynews.com/tag/car-t/ " rel="tag">CAR-T</a> </li> <li class="post-single__tag-item"> <a class="post-single__tag" href="https://medcitynews.com/tag/cell-therapy/ " rel="tag">cell therapy</a> </li> <li class="post-single__tag-item"> <a class="post-single__tag" href="https://medcitynews.com/tag/fda/ " rel="tag">FDA</a> </li> </ul> </div> <section class="newsletter-signup form-interruptor"> <header class="newsletter-signup__header"> <h2 class="newsletter-signup__title"> MedCity News Daily Newsletter </h2> <h3 class="newsletter-signup__subtitle"> Sign up and get the latest news in your inbox. </h3> </header> <form class="newsletter-signup__form" data-hs-cf-bound="true"> <div class="newsletter-signup__field-group"> <label for="newsletter-signup-email" class="visually-hidden">Enter your email address</label> <input id="newsletter-signup-email" class="newsletter-signup__field newsletter-signup__field--email" type="email" name="email" placeholder="Enter your email address"> <button class="newsletter-signup__submit">Subscribe Now</button> </div> </form> <footer class="newsletter-signup__footer"> <p class="newsletter-signup__disclaimer"> We will never sell or share your information without your consent. See our <a href="#">privacy policy</a>. </p> </footer> </section> <div class="related-posts"> <h2 class="related-posts__title"> <span>More from MedCity News</span> </h2> <div class="related-posts__items"> <div class="post-card__wrapper "> <article id="post-134407" class="post-card post-card--has-thumbnail " data-title="Recursion Pharma Accelerator Steps In to Fill Some of the Funding Gap Amid NIH Tumult" data-url="https://medcitynews.com/2025/02/recursion-biotech-startup-accelerator-altitude-lab-nih-grant-utah-rxrx/"> <figure class="post-card__thumbnail"> <a href="https://medcitynews.com/2025/02/recursion-biotech-startup-accelerator-altitude-lab-nih-grant-utah-rxrx/" class="post-card__thumbnail-link" > <img width="360" height="200" src="https://medcitynews.com/wp-content/uploads/sites/7/2025/02/GettyImages-129732110-360x200.jpg" class="attachment-post-card-sm size-post-card-sm wp-post-image" alt="" style="" decoding="async" srcset="https://medcitynews.com/wp-content/uploads/sites/7/2025/02/GettyImages-129732110-360x200.jpg 360w, https://medcitynews.com/wp-content/uploads/sites/7/2025/02/GettyImages-129732110-576x320.jpg 576w" sizes="(max-width: 360px) 100vw, 360px" /> </a> </figure> <div class="post-card__content"> <h3 class="post-card__title"> <a href="https://medcitynews.com/2025/02/recursion-biotech-startup-accelerator-altitude-lab-nih-grant-utah-rxrx/" class="post-single__title-link" > Recursion Pharma Accelerator Steps In to Fill Some of the Funding Gap Amid NIH Tumult </a> </h3> </div> </article> </div> <div class="post-card__wrapper "> <article id="post-134409" class="post-card post-card--has-thumbnail " data-title="How Tampa General Hospital’s Partnership with Palantir Is Shortening Its Innovation Timelines" data-url="https://medcitynews.com/2025/02/palantir-tampa-general-innovation-tech/"> <figure class="post-card__thumbnail"> <a href="https://medcitynews.com/2025/02/palantir-tampa-general-innovation-tech/" class="post-card__thumbnail-link" > <img width="300" height="200" src="https://medcitynews.com/wp-content/uploads/sites/7/2023/07/GettyImages-1379013647.jpg" class="attachment-post-card-sm size-post-card-sm wp-post-image" alt="speed" style="" decoding="async" srcset="https://medcitynews.com/wp-content/uploads/sites/7/2023/07/GettyImages-1379013647.jpg 724w, https://medcitynews.com/wp-content/uploads/sites/7/2023/07/GettyImages-1379013647-300x200.jpg 300w, https://medcitynews.com/wp-content/uploads/sites/7/2023/07/GettyImages-1379013647-600x400.jpg 600w" sizes="(max-width: 300px) 100vw, 300px" /> </a> </figure> <div class="post-card__content"> <h3 class="post-card__title"> <a href="https://medcitynews.com/2025/02/palantir-tampa-general-innovation-tech/" class="post-single__title-link" > How Tampa General Hospital’s Partnership with Palantir Is Shortening Its Innovation Timelines </a> </h3> </div> </article> </div> <div class="post-card__wrapper "> <article id="post-134398" class="post-card post-card--has-thumbnail " data-title="Attention Healthcare and Life Science Startups: Deadline for INVEST Pitch Perfect Contest Submissions is Feb 21" data-url="https://medcitynews.com/2025/02/attention-healthcare-and-life-science-startups-deadline-for-invest-pitch-perfect-contest-submissions-is-feb-21/"> <figure class="post-card__thumbnail"> <a href="https://medcitynews.com/2025/02/attention-healthcare-and-life-science-startups-deadline-for-invest-pitch-perfect-contest-submissions-is-feb-21/" class="post-card__thumbnail-link" > <img width="300" height="200" src="https://medcitynews.com/wp-content/uploads/sites/7/2024/02/GettyImages-80284335.jpg" class="attachment-post-card-sm size-post-card-sm wp-post-image" alt="" style="" decoding="async" srcset="https://medcitynews.com/wp-content/uploads/sites/7/2024/02/GettyImages-80284335.jpg 724w, https://medcitynews.com/wp-content/uploads/sites/7/2024/02/GettyImages-80284335-300x200.jpg 300w, https://medcitynews.com/wp-content/uploads/sites/7/2024/02/GettyImages-80284335-600x400.jpg 600w" sizes="(max-width: 300px) 100vw, 300px" /> </a> </figure> <div class="post-card__content"> <h3 class="post-card__title"> <a href="https://medcitynews.com/2025/02/attention-healthcare-and-life-science-startups-deadline-for-invest-pitch-perfect-contest-submissions-is-feb-21/" class="post-single__title-link" > Attention Healthcare and Life Science Startups: Deadline for INVEST Pitch Perfect Contest Submissions is Feb 21 </a> </h3> </div> </article> </div> <div class="post-card__wrapper "> <article id="post-134385" class="post-card post-card--has-thumbnail " data-title="Aetna Taps InStride Health for Specialty Youth Mental Health" data-url="https://medcitynews.com/2025/02/aetna-youth-mental-health/"> <figure class="post-card__thumbnail"> <a href="https://medcitynews.com/2025/02/aetna-youth-mental-health/" class="post-card__thumbnail-link" > <img width="343" height="200" src="https://medcitynews.com/wp-content/uploads/sites/7/2021/08/Therapy-app.jpg" class="attachment-post-card-sm size-post-card-sm wp-post-image" alt="" style="" decoding="async" srcset="https://medcitynews.com/wp-content/uploads/sites/7/2021/08/Therapy-app.jpg 773w, https://medcitynews.com/wp-content/uploads/sites/7/2021/08/Therapy-app-300x175.jpg 300w, https://medcitynews.com/wp-content/uploads/sites/7/2021/08/Therapy-app-600x350.jpg 600w, https://medcitynews.com/wp-content/uploads/sites/7/2021/08/Therapy-app-768x448.jpg 768w" sizes="(max-width: 343px) 100vw, 343px" /> </a> </figure> <div class="post-card__content"> <h3 class="post-card__title"> <a href="https://medcitynews.com/2025/02/aetna-youth-mental-health/" class="post-single__title-link" > Aetna Taps InStride Health for Specialty Youth Mental Health </a> </h3> </div> </article> </div> </div> </div> </footer> </article> <aside class="sidebar" id="sidebar"> <div class="sidebar__top-sticky sidebar__sticky-container" id="sidebar__top-sticky"> <div class="sidebar__sticky__inner-wrap sidebar__top-sticky__inner-wrap"> <div class="ad ad--top_sidebar ad--format-square ad--sidebar_sticky ad--desktop-only" id="ad--top_sidebar top_sidebar"> <div class="ad__wrapper"> <div id="ad-top_sidebar"></div> </div> </div> </div> </div> <div class="sidebar__sponsored sidebar__sponsored--top" id="sidebar__sponsored--top"> <article id="post-134319" class="post-card post-card--has-thumbnail post-card--mobile-thumbnail post-card--is-sponsored " data-title="Tips for Greater Healthcare Practice Success in 2025" data-url="https://info.medcitynews.com/tips-for-greater-healthcare-practice-success-in-2025"> <figure class="post-card__thumbnail"> <a href="https://info.medcitynews.com/tips-for-greater-healthcare-practice-success-in-2025" class="post-card__thumbnail-link" > <img width="576" height="320" src="https://medcitynews.com/wp-content/uploads/sites/7/2025/02/elation-health-webinar-thumb-1-576x320.jpg" class="attachment-post-card size-post-card wp-post-image" alt="" style="" decoding="async" srcset="https://medcitynews.com/wp-content/uploads/sites/7/2025/02/elation-health-webinar-thumb-1-576x320.jpg 576w, https://medcitynews.com/wp-content/uploads/sites/7/2025/02/elation-health-webinar-thumb-1-360x200.jpg 360w" sizes="(max-width: 576px) 100vw, 576px" /> </a> </figure> <div class="post-card__content"> <div class="post-card__categories"> <span class="post-single__category post-single__category--text"> <a href="https://medcitynews.com/category/sponsored-post/" rel="category tag"> Sponsored Post </a> </span> </div> <h3 class="post-card__title"> <a href="https://info.medcitynews.com/tips-for-greater-healthcare-practice-success-in-2025" class="post-single__title-link" > Tips for Greater Healthcare Practice Success in 2025 </a> </h3> <p class="post-card__excerpt content">Join us on February 26 at 3 pm ET, and we’ll dive into the key areas where practices are losing time and money and provide solutions to overcome them. </p> <div class="post-card__byline"> <a href="https://medcitynews.com/2024/11/autolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia/"> By Elation Health and MedCity News </a> </div> </div> </article> </div> <div class="sidebar__recommended" id="bd-recommended-sidebar"> <div class="sidebar__recommended-content"> <h2 class="sidebar-recommended__category"> Recommended </h2> <div class="recommended-posts"> <div class="post-card__wrapper "> <article id="post-134372" class="post-card post-card--has-thumbnail " data-title="Blood Centers Complement Hospitals to Drive Cell and Gene Therapy Access" data-url="https://medcitynews.com/2025/02/blood-centers-complement-hospitals-to-drive-cell-and-gene-therapy-access/"> <div class="post-card__categories"> <span class="post-single__category post-single__category--text"> <a href="https://medcitynews.com/category/medcity-influencers/" rel="category tag"> MedCity Influencers </a> </span> </div> <div class="post-card__content"> <h3 class="post-card__title"> <a href="https://medcitynews.com/2025/02/blood-centers-complement-hospitals-to-drive-cell-and-gene-therapy-access/" class="post-single__title-link" > Blood Centers Complement Hospitals to Drive Cell and Gene Therapy Access </a> </h3> </div> </article> </div> <div class="post-card__wrapper "> <article id="post-134438" class="post-card post-card--has-thumbnail " data-title="Millie Raises $12M to Advance Maternal Healthcare" data-url="https://medcitynews.com/2025/02/maternal-health-fundraise-millie/"> <div class="post-card__categories"> <span class="post-single__category post-single__category--text"> <a href="https://medcitynews.com/category/channel/health-tech/" rel="category tag"> Health Tech </a> </span> </div> <div class="post-card__content"> <h3 class="post-card__title"> <a href="https://medcitynews.com/2025/02/maternal-health-fundraise-millie/" class="post-single__title-link" > Millie Raises $12M to Advance Maternal Healthcare </a> </h3> </div> </article> </div> <div class="post-card__wrapper "> <article id="post-134431" class="post-card post-card--has-thumbnail " data-title="AstraZeneca Secures China Rights to Anemia Drug, Buying FibroGen Unit in $160M Deal" data-url="https://medcitynews.com/2025/02/astrazeneca-fibrogen-china-roxadustat-anemia-drug-azn-fgen/"> <div class="post-card__categories"> <span class="post-single__category post-single__category--text"> <a href="https://medcitynews.com/category/channel/biopharma/" rel="category tag"> BioPharma </a> </span> </div> <div class="post-card__content"> <h3 class="post-card__title"> <a href="https://medcitynews.com/2025/02/astrazeneca-fibrogen-china-roxadustat-anemia-drug-azn-fgen/" class="post-single__title-link" > AstraZeneca Secures China Rights to Anemia Drug, Buying FibroGen Unit in $160M Deal </a> </h3> </div> </article> </div> </div> </div> </div> <div class="sidebar__sponsored sidebar__sponsored--middle" id="sidebar__sponsored-middle"> <article id="post-133107" class="post-card post-card--has-thumbnail post-card--mobile-thumbnail post-card--is-sponsored " data-title="Using Data to Help Healthcare Practices Succeed" data-url="https://medcitynews.com/2025/01/using-data-to-help-healthcare-practices-succeed/"> <figure class="post-card__thumbnail"> <a href="https://medcitynews.com/2025/01/using-data-to-help-healthcare-practices-succeed/" class="post-card__thumbnail-link" > <img width="481" height="320" src="https://medcitynews.com/wp-content/uploads/sites/7/2020/01/Getty-health-record-ipopba.jpg" class="attachment-post-card size-post-card wp-post-image" alt="" style="" decoding="async" srcset="https://medcitynews.com/wp-content/uploads/sites/7/2020/01/Getty-health-record-ipopba.jpg 724w, https://medcitynews.com/wp-content/uploads/sites/7/2020/01/Getty-health-record-ipopba-300x200.jpg 300w, https://medcitynews.com/wp-content/uploads/sites/7/2020/01/Getty-health-record-ipopba-600x399.jpg 600w" sizes="(max-width: 481px) 100vw, 481px" /> </a> </figure> <div class="post-card__content"> <div class="post-card__categories"> <span class="post-single__category post-single__category--text"> <a href="https://medcitynews.com/category/health-care/" rel="category tag"> Healthcare </a> </span> </div> <h3 class="post-card__title"> <a href="https://medcitynews.com/2025/01/using-data-to-help-healthcare-practices-succeed/" class="post-single__title-link" > Using Data to Help Healthcare Practices Succeed </a> </h3> <p class="post-card__excerpt content">A new report from Relatient, A Data-Driven Guide to Patient Access Succes, highlights how focusing on data accuracy and relevance can enhance the performance of healthcare practices.</p> <div class="post-card__byline"> <a href="https://medcitynews.com/2024/11/autolus-car-t-cell-therapy-obe-cel-aucatzyl-fda-approval-b-cell-all-blood-cancer-leukemia/"> By Relatient </a> </div> </div> </article> </div> <div class="sidebar__middle-sticky sidebar__sticky-container sidebar__sticky" id="sidebar__middle-sticky"> <div class="sidebar__sticky__inner-wrap sidebar__middle-sticky__inner-wrap"> <div class="ad ad--middle_sidebar ad--format-square ad--sidebar_sticky ad--desktop-only" id="ad--middle_sidebar middle_sidebar"> <div class="ad__wrapper"> <div id="ad-middle_sidebar"></div> </div> </div> </div> </div> <div class="sidebar__sponsored sidebar__sponsored--bottom" id="sidebar__sponsored-bottom"> <article id="post-131258" class="post-card post-card--has-thumbnail post-card--mobile-thumbnail post-card--is-sponsored " data-title="Transforming Patient Care: The Role of AI-Powered Assistants" data-url="https://medcitynews.com/2024/12/transforming-patient-care-the-role-of-ai-powered-assistants/"> <figure class="post-card__thumbnail"> <a href="https://medcitynews.com/2024/12/transforming-patient-care-the-role-of-ai-powered-assistants/" class="post-card__thumbnail-link" > <img width="576" height="320" src="https://medcitynews.com/wp-content/uploads/sites/7/2024/11/pic1-576x320.jpg" class="attachment-post-card size-post-card wp-post-image" alt="" style="" decoding="async" srcset="https://medcitynews.com/wp-content/uploads/sites/7/2024/11/pic1-576x320.jpg 576w, https://medcitynews.com/wp-content/uploads/sites/7/2024/11/pic1-360x200.jpg 360w" sizes="(max-width: 576px) 100vw, 576px" /> </a> </figure> <div class="post-card__content"> <div class="post-card__categories"> <span class="post-single__category post-single__category--text"> <a href="https://medcitynews.com/category/channel/health-it-channel/" rel="category tag"> Health IT </a> </span> </div> <h3 class="post-card__title"> <a href="https://medcitynews.com/2024/12/transforming-patient-care-the-role-of-ai-powered-assistants/" class="post-single__title-link" > Transforming Patient Care: The Role of AI-Powered Assistants </a> </h3> <p class="post-card__excerpt content">The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.</p> <div class="post-card__byline"> <a href="https://bit.ly/48CMz0L"> By IT Medical </a> </div> </div> </article> </div> <div class="sidebar__bottom-sticky sidebar__sticky-container sidebar__sticky" id="sidebar__bottom-sticky"> <div class="sidebar__sticky__inner-wrap sidebar__top-sticky__inner-wrap"> <div class="ad ad--bottom_sidebar ad--format-square ad--sidebar_sticky ad--desktop-only" id="ad--bottom_sidebar bottom_sidebar"> <div class="ad__wrapper"> <div id="ad-bottom_sidebar"></div> </div> </div> </div> </div> <section class="newsletter-signup form-interruptor"> <header class="newsletter-signup__header"> <h2 class="newsletter-signup__title"> MedCity News Daily Newsletter </h2> <h3 class="newsletter-signup__subtitle"> Sign up and get the latest news in your inbox. </h3> </header> <form class="newsletter-signup__form" data-hs-cf-bound="true"> <div class="newsletter-signup__field-group"> <label for="newsletter-signup-email" class="visually-hidden">Enter your email address</label> <input id="newsletter-signup-email" class="newsletter-signup__field newsletter-signup__field--email" type="email" name="email" placeholder="Enter your email address"> <button class="newsletter-signup__submit">Subscribe Now</button> </div> </form> <footer class="newsletter-signup__footer"> <p class="newsletter-signup__disclaimer"> We will never sell or share your information without your consent. See our <a href="#">privacy policy</a>. </p> </footer> </section> </aside> </main> <div class="ad ad--bottom_leaderboard ad--format-leaderboard" id="ad--bottom_leaderboard bottom_leaderboard"> <div class="ad__wrapper"> <div id="ad-bottom_leaderboard"></div> </div> </div> </div><!-- #site-main --> <footer id="site-footer" class="site-footer"> <div class="site-footer__container"> <nav class="nav-footer"> <ul id="site-footer" class="nav-footer__items"><li id="menu-item-44946" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-44946"><a href="https://medcitynews.com/ads/">Advertise</a></li> <li id="menu-item-44949" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-44949"><a href="https://medcitynews.com/about-us/">About</a></li> <li id="menu-item-44952" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-44952"><a href="https://medcitynews.com/subscribe/">Newsletter</a></li> </ul></nav> <div class="site-footer__sites"> <h2 class="site-footer__sites-title"> <span>Our Sites</span> </h2> <div class="site-footer__logo-grid"> <figure class="site-footer__logo"> <a href="https://abovethelaw.com/" target="_blank"> <img src="https://medcitynews.com/wp-content/themes/breakingmedia/dist//images/above-the-law.webp" alt="Above the Law" loading="lazy"> </a> </figure> <figure class="site-footer__logo"> <a href="https://howappealing.abovethelaw.com/" target="_blank"> <img src="https://medcitynews.com/wp-content/themes/breakingmedia/dist//images/logo-how-appealing.webp" alt="How Appealing" loading="lazy"> </a> </figure> <figure class="site-footer__logo"> <a href="https://breakingdefense.com/" target="_blank"> <img src="https://medcitynews.com/wp-content/themes/breakingmedia/dist//images/breaking-defense.webp" alt="Breaking Defense" loading="lazy"> </a> </figure> <figure class="site-footer__logo"> <a href="https://breakingenergy.com/" target="_blank"> <img src="https://medcitynews.com/wp-content/themes/breakingmedia/dist//images/breaking-energy.webp" alt="Breaking Energy" loading="lazy"> </a> </figure> <figure class="site-footer__logo"> <a href="https://breakinggov.com/" target="_blank"> <img src="https://medcitynews.com/wp-content/themes/breakingmedia/dist//images/breaking-gov.webp" alt="Breaking Gov" loading="lazy"> </a> </figure> <figure class="site-footer__logo"> <a href="https://dealbreaker.com/" target="_blank"> <img src="https://medcitynews.com/wp-content/themes/breakingmedia/dist//images/dealbreaker.webp" alt="Deal Breaker" loading="lazy"> </a> </figure> <figure class="site-footer__logo"> <a href="https://fashionista.com/" target="_blank"> <img src="https://medcitynews.com/wp-content/themes/breakingmedia/dist//images/fashionista-logo.webp" alt="Fashionista" loading="lazy"> </a> </figure> <figure class="site-footer__logo"> <a href="https://medcitynews.com/" target="_blank"> <img src="https://medcitynews.com/wp-content/themes/breakingmedia/dist//images/medcity-news.webp" alt="Med City News" loading="lazy"> </a> </figure> </div> </div> <p class="site-footer__legal"> &copy; 2025 Breaking Media, Inc. All rights reserved. Registration or use of this site constitutes acceptance of our <a href="https://medcitynews.com/medcitizen-terms-of-service/">Terms of Service</a> and <a href="https://medcitynews.com/privacy-policy/">Privacy Policy</a>. </p> <div class="site-footer__dmca"> <a href="https://www.dmca.com/compliance/abovethelaw.com" title="DMCA Compliance information for abovethelaw.com" target="_blank" rel="noopener nofollow"><img src="https://www.dmca.com/img/Compliance-Trace-White.svg" alt="DMCA compliant image" style="width: 120px; height: auto;" /></a> </div> </div> </footer> </div> <!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: INVEST 2025 Super Early Bird Pop-Up 01.22.25 --> <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,71761,'bft0hx0flbykomx1tdwr');</script> <!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2025 MedCity News Lock --> <script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,71761,'zdw9vmzlyxiy1wwsubpc');</script> <!-- / OptinMonster --> <script type="text/javascript"> var bft0hx0flbykomx1tdwr_shortcode = true;var zdw9vmzlyxiy1wwsubpc_shortcode = true; </script> <script type="text/javascript" id="molongui-authorship-byline-js-extra"> /* <![CDATA[ */ var molongui_authorship_byline_params = {"byline_prefix":"","byline_suffix":"","byline_separator":", ","byline_last_separator":" and ","byline_link_title":"View all posts by","byline_link_class":"","byline_dom_tree":"","byline_dom_prepend":"","byline_dom_append":"","byline_decoder":"v3"}; /* ]]> */ </script> <script type="text/javascript" src="https://medcitynews.com/wp-content/plugins/molongui-authorship/assets/js/byline.334a.min.js?ver=4.9.7" id="molongui-authorship-byline-js"></script> <script type="text/javascript" src="https://medcitynews.com/wp-content/themes/medcitynews/dist/js/frontend.js?ver=8cc541636417109a581d" id="mcn-frontend-js"></script> <script type="text/javascript" src="https://medcitynews.com/wp-content/themes/medcitynews/dist/js/shared.js?ver=8c5b220bf6f482881a90" id="mcn-shared-js"></script> <script type="text/javascript" src="https://medcitynews.com/wp-includes/js/dist/hooks.min.js?ver=4d63a3d491d11ffd8ac6" id="wp-hooks-js"></script> <script type="text/javascript" src="https://medcitynews.com/wp-includes/js/dist/i18n.min.js?ver=5e580eb46a90c2b997e6" id="wp-i18n-js"></script> <script type="text/javascript" id="wp-i18n-js-after"> /* <![CDATA[ */ wp.i18n.setLocaleData( { 'text direction\u0004ltr': [ 'ltr' ] } ); /* ]]> */ </script> <script type="text/javascript" src="https://medcitynews.com/wp-content/themes/breakingmedia/dist/js/frontend.js?ver=fe6247813520f8fa9994" id="frontend-js"></script> <script type="text/javascript" src="https://medcitynews.com/wp-content/themes/breakingmedia/dist/js/shared.js?ver=ea575ec024756abfccb7" id="shared-js"></script> <script>(function(d){var s=d.createElement("script");s.type="text/javascript";s.src="https://a.omappapi.com/app/js/api.min.js";s.async=true;s.id="omapi-script";d.getElementsByTagName("head")[0].appendChild(s);})(document);</script><script type="text/javascript" src="https://medcitynews.com/wp-content/plugins/optinmonster/assets/dist/js/helper.min.js?ver=2.16.5" id="optinmonster-wp-helper-js"></script> <div id="parsely-root" style="display: none"> <span id="parsely-cfg" data-parsely-site="medcitynews.com"></span> </div> <script> (function(s, p, d) { var h=d.location.protocol, i=p+"-"+s, e=d.getElementById(i), r=d.getElementById(p+"-root"), u=h==="https:"?"d1z2jf7jlzjs58.cloudfront.net" :"static."+p+".com"; if (e) return; e = d.createElement(s); e.id = i; e.async = true; e.src = h+"//"+u+"/p.js"; r.appendChild(e); })("script", "parsely", document); </script> <script type="text/javascript">var omapi_localized = { ajax: 'https://medcitynews.com/wp-admin/admin-ajax.php?optin-monster-ajax-route=1', nonce: '7fc28d3c48', slugs: {"bft0hx0flbykomx1tdwr":{"slug":"bft0hx0flbykomx1tdwr","mailpoet":false},"zdw9vmzlyxiy1wwsubpc":{"slug":"zdw9vmzlyxiy1wwsubpc","mailpoet":false}} };</script> <script type="text/javascript">var omapi_data = {"object_id":131438,"object_key":"post","object_type":"post","term_ids":[69,63,123,54,41459,52204,42325,41851,14217,37220,29460,6207],"wp_json":"https:\/\/medcitynews.com\/wp-json","wc_active":false,"edd_active":false,"nonce":"ef1c1c0905"};</script> <div id="sticky-footer-ad-container" class="sticky-footer-ad-container"> <div class="sticky-footer-ad__close js-sticky-footer-ad__close">&times;</div> <div class="ad ad--bottom_sticky ad--format-mobile-leaderboard" id="ad--bottom_sticky bottom_sticky"> <div class="ad__wrapper"> <div id="ad-bottom_sticky"></div> </div> </div> </div> </div> </body> </html>

Pages: 1 2 3 4 5 6 7 8 9 10